Advanced Analytics for Therapeutic Proteins: from Research to Manufacturing

Development and manufacturing of biopharmaceuticals requires highly sophisticated analytics at all stages of the process. These drug development programs are currently facing a higher attrition rate and an increasing regulatory demand to characterize the product and manufacturing process. More recently, the emerging portfolio of biosimilar programs is driving another leap in understanding how the manufacturing process defines product quality.
The conference ‘Advanced Analytics for Therapeutic Proteins: from Research to Manufacturing’ aims to bring researchers from academia and industry together to discuss novel trends in analytical science. It will be focused on all approaches that aim to lower attrition, improve characterization of products and impurities and increase process knowledge and safety.
International leaders in the field will present today’s technology and an outlook on the future. Furthermore, the program offers an excellent opportunity to present your latest scientific results in oral and poster sessions; contributions are invited on all conference topics.